Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators

We demonstrate that combined treatment with metformin (Met) or its mitochondria-targeted analog, mito-metformin (Mito-Met), and various iron chelators synergistically inhibits proliferation of pancreatic and triple-negative breast cancer cells. Previously, we reported that Met (at millimolar levels)...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Gang, Zielonka, Jacek, Hardy, Micael, Ouari, Olivier, Chitambar, Christopher R., Dwinell, Michael B., Kalyanaraman, Balaraman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544408/
https://www.ncbi.nlm.nih.gov/pubmed/31191823
http://dx.doi.org/10.18632/oncotarget.26943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544408/
https://www.ncbi.nlm.nih.gov/pubmed/31191823
http://dx.doi.org/10.18632/oncotarget.26943

Ejemplares similares